Skip to main content
Baricitinib allows flexibility in dosing regimens up to 104 weeks in moderate-to-severe atopic dermatitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Baricitinib allows flexibility in dosing regimens up to 104 weeks in moderate-to-severe atopic dermatitis
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Atopic Dermatitis
0
1
Eczema
0
0.75
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
0.7
Edit Tags